Catalyst Pharmaceuticals (CPRX) Intangibles (2022 - 2026)

Catalyst Pharmaceuticals' Intangibles history runs 5 years deep, the most recent figure standing at $240.2 million for Q1 2026.

• Quarterly Intangibles rose 63.05% year-over-year to $240.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $240.2 million (up 63.05% YoY) and the FY2025 annual result came in at $240.2 million, up 53.32% from the prior year.
• Intangibles was $240.2 million for Q1 2026 at Catalyst Pharmaceuticals, roughly flat from $240.2 million in the prior quarter.
• Across five years, Intangibles topped out at $240.2 million in Q4 2025 and bottomed at $32.5 million in Q4 2022.
• A 5-year average of $166.4 million and a median of $175.4 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2023 — Intangibles jumped 601.28% — and 2024, when it tumbled 31.2%.
• Catalyst Pharmaceuticals' Intangibles stood at $32.5 million in 2022, then soared by 601.28% to $227.7 million in 2023, then plunged by 31.2% to $156.7 million in 2024, then jumped by 53.32% to $240.2 million in 2025, then changed by 0.0% to $240.2 million in 2026.
• Business Quant data shows CPRX's Intangibles at $240.2 million in Q1 2026, $240.2 million in Q4 2025, and $227.7 million in Q3 2025.